Researchers have developed a new approach to T cell therapy that is more effective in killing triple-negative breast cancer (TNBC) cells. This new approach uses a combination of peptides to activate T cells to target and kill cancer cells. The researchers found that this approach was more effective than traditional T cell therapy. This is good news for patients with TNBC, as it could lead to more effective treatments.
เงินทุน
This work was supported by the Siriraj Research Fund, Faculty of Medicine Siriraj Hospital, Mahidol University (R016334002 and R016737004).
กระดาษต้นฉบับ
ชื่อบทความต้นฉบับ: Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells
วารสาร: BMC Medicine
ดอย: https://doi.org/10.1186/s12916-024-03625-3